Exome Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,257
Closed -$764K 70
2023
Q4
$764K Buy
+35,257
New +$764K 0.76% 39